GlassScriptPhysician profile
Brian Kenny Armstrong
NPI 1285781179
$12,851.93
in general payments reported to CMS, 2019-2025
10 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $273 · 2023: $66.44 · 2024: $1,585 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,138 · Food and Beverage: $3,133 · Travel and Lodging: $1,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,137.50 |
| Food and Beverage | $3,132.83 |
| Travel and Lodging | $1,309.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $9,799.85 | 2025 | Epioxa, Travoprost Intraocular Implant - Idose |
| Alcon Vision LLC | $1,232.49 | 2024-2025 | Wavelight Ex500 Excimer Laser, Clareon, Wavelight Refractive Suite |
| Bausch & Lomb Americas INC. | $792.63 | 2022-2025 | Miebo, Xiidra, Xipere |
| Carl Zeiss Meditec USA, INC. | $296.68 | 2022-2024 | Callisto Eye |
| Dompe US, INC. | $210.93 | 2022-2025 | Oxervate |
| Rxsight INC | $163.19 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Genentech USA, INC. | $146.09 | 2024 | Vabysmo |
| Seagen INC. | $95.38 | 2022 | |
| Harrow Eye, LLC | $92.47 | 2024 | Flarex |
| Amgen INC. | $22.22 | 2024 | Tavneos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.